Delivery Order SPE2DB20D2104-SPE2DB24FV32B

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $37K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,407.58 firm fixed-price delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,745.57 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of November 24, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,554.39 firm fixed price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,765.47 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,632.59 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has a completion date of December 4, 2024 and was awarded on December 3, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,489.35 firm fixed-price delivery order is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of June 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $14,729.86 for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medication. The $62,005.26 delivery order contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2025. The contract is not set-aside and represents an order under AmerisourceBergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,745.60, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 30, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV32B
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,547.33, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. This is a firm fixed-price delivery order contract with a completion date of July 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 12:23 PM